LOOPLIGASE Trademark

Trademark Overview


On Tuesday, September 22, 2020, a trademark application was filed for LOOPLIGASE with the United States Patent and Trademark Office. The USPTO has given the LOOPLIGASE trademark a serial number of 90199980. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Thursday, March 7, 2024. This trademark is owned by Qiagen Beverly, LLC. The LOOPLIGASE trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Diagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits comprised of preparations for medical and veterinary diagnostic purposes, namely, preparations for marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes

Chemical, biochemical and biotechnological diagnostic preparations for scientific purposes, namely, buffer solutions for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; chemical test kits for laboratory or research use featuring chemicals for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification and cloning
loopligase

General Information


Serial Number90199980
Word MarkLOOPLIGASE
Filing DateTuesday, September 22, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateThursday, March 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 17, 2021

Trademark Statements


Goods and ServicesDiagnostic preparations for medical and veterinary purposes, namely, diagnostics preparations for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely, reagents, enzymes and buffer solutions for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits comprised of preparations for medical and veterinary diagnostic purposes, namely, preparations for marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, namely, nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification and cloning for medical or veterinary purposes
Pseudo MarkLOOP LI G ASE
Goods and ServicesChemical, biochemical and biotechnological diagnostic preparations for scientific purposes, namely, buffer solutions for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification and cloning; chemical test kits for laboratory or research use featuring chemicals for the marking, separating, isolating, amplifying, cloning, sequencing and analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification and cloning

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, October 30, 2020
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQiagen Beverly, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBeverly, MA 01915

Party NameQiagen Beverly, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBeverly, MA 01915

Trademark Events


Event DateEvent Description
Friday, September 25, 2020NEW APPLICATION ENTERED
Friday, October 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 8, 2021ASSIGNED TO EXAMINER
Monday, February 15, 2021NON-FINAL ACTION WRITTEN
Monday, February 15, 2021NON-FINAL ACTION E-MAILED
Monday, February 15, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 7, 2021ASSIGNED TO LIE
Tuesday, June 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 8, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 9, 2021ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, July 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 14, 2021ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, July 28, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 17, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 17, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 12, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 18, 2022SOU TEAS EXTENSION RECEIVED
Friday, March 18, 2022SOU EXTENSION 1 FILED
Friday, March 18, 2022SOU EXTENSION 1 GRANTED
Monday, October 10, 2022SOU EXTENSION 2 GRANTED
Tuesday, March 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 10, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 10, 2022SOU EXTENSION 2 FILED
Wednesday, October 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 3, 2023SOU EXTENSION 3 GRANTED
Friday, March 3, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 3, 2023SOU EXTENSION 3 FILED
Monday, September 11, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 11, 2023SOU EXTENSION 4 FILED
Monday, September 11, 2023SOU EXTENSION 4 GRANTED
Thursday, March 7, 2024SOU EXTENSION 5 GRANTED
Tuesday, March 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 7, 2024SOU TEAS EXTENSION RECEIVED
Thursday, March 7, 2024SOU EXTENSION 5 FILED
Friday, March 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED